United States · Wires & real time · Business Wire

Takeda Launches ORZEYFUL™ (oveporexton), the First and Only Medicine of Its Kind for Narcolepsy Type 1 Now Available in the United States

Published by Business Wire · United States 1 d ago

Detailed summary

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) announced that ORZEYFUL™ (oveporexton) CIV is now available in the U.S. by prescription for the…

Read the full article on Business Wire Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.businesswire.com)

Also worth reading

PR Newswire

Vijit Chao Phraya 2026 brings a month-long spectacle of light and imagination to Bangkok's riverfront

Associated Press (Business)

Why professional networking is a job search asset that AI can’t replace

Dow Jones Newswires

Prospects for the global economy in 2027

MT Newswires